Clinical trials
Gastroesophageal Reflux trials in China with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 5 |
| 2025 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 7 |
| Completed | 6 |
| Recruiting | 5 |
| Not yet recruiting | 3 |
| Active, not recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Beijing Friendship Hospital | 2 |
| China-Japan Friendship Hospital | 2 |
| Chinese University of Hong Kong | 2 |
| Hospital Authority, Hong Kong | 2 |
| Affiliated Hospital to Academy of Military Medical Sciences | 1 |
| Air Force Military Medical University, China | 1 |
| Beijing Chao Yang Hospital | 1 |
| Changhai Hospital | 1 |
| Chinese PLA General Hospital | 1 |
| First Affiliated Hospital of Jinan University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gastroesophageal Reflux | 23 |
| Hernia, Hiatal | 2 |
| Weight Loss | 2 |
| Bile Reflux | 1 |
| Dyspepsia | 1 |
| Esophageal Achalasia | 1 |
| Esophagitis, Peptic | 1 |
| Heartburn | 1 |
| Laryngitis | 1 |
| Non-Erosive Reflux Disease | 1 |
Trials
Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.